InDex Pharmaceuticals has been granted a new patent in Europe for the commercial formulation of cobitolimod

By /

InDex Pharmaceuticals Holding AB announced that a new formulation patent for the drug candidate cobitolimod has been granted by the European Patent Office.

Scroll to Top